» Authors » Ken Ishikura

Ken Ishikura

Explore the profile of Ken Ishikura including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 352
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kinoshita G, Ito-Masui A, Kato T, Okuno F, Ikejiri K, Ishikura K, et al.
J Artif Organs . 2024 Jun; PMID: 38916825
Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a rescue therapy for severe respiratory failure in which conventional mechanical ventilation therapy is unsuccessful. Hemolysis during VV-ECMO support arises from multiple factors associated...
2.
Kasugai D, Tanaka T, Suzuki T, Ito Y, Nishida K, Ozaki M, et al.
Front Immunol . 2024 Mar; 15:1337070. PMID: 38529277
Background: Coronavirus disease 2019 (COVID-19) features a hypercoagulable state, but therapeutic anticoagulation effectiveness varies with disease severity. We aimed to evaluate the dynamics of the coagulation profile and its association...
3.
Nishikimi M, Ohshimo S, Hamaguchi J, Fujizuka K, Hagiwara Y, Anzai T, et al.
BMJ Open . 2023 Oct; 13(10):e072680. PMID: 37852764
Introduction: While limiting the tidal volume to 6 mL/kg during veno-venous extracorporeal membrane oxygenation (V-V ECMO) to ameliorate lung injury in patients with acute respiratory distress syndrome (ARDS) is widely...
4.
Yamamoto R, Yamakawa K, Endo A, Homma K, Sato Y, Takemura R, et al.
BMJ Open . 2023 Sep; 13(9):e074475. PMID: 37714682
Introduction: Cardiac arrest is a critical condition, and patients often experience postcardiac arrest syndrome (PCAS) even after the return of spontaneous circulation (ROSC). Administering a restricted amount of oxygen in...
5.
Okuno F, Ito-Masui A, Hane A, Maeyama K, Ikejiri K, Ishikura K, et al.
Int J Emerg Med . 2023 Aug; 16(1):52. PMID: 37635211
Background: Severe hypocalcemia may lead to life-threatening arrhythmias. Denosumab is an effective treatment for osteoporosis that allows long intervals between doses. However, there is a risk of hypocalcemia in some...
6.
Yokoyama K, Kaneko T, Ieki Y, Ito A, Kawamoto E, Suzuki K, et al.
Cureus . 2023 Mar; 15(2):e35233. PMID: 36968897
Background: Positive end-expiratory pressure (PEEP), especially continuous high PEEP, is thought to be a risk factor for worsening renal function (WRF) due to impaired venous return and the development of...
7.
Moriwaki K, Kurita T, Hirota Y, Ito H, Ishise T, Fujimoto N, et al.
Circ J . 2023 Mar; 87(5):629-639. PMID: 36928102
Background: The simple risk index recorded in the emergency room (ER-SRI), which is calculated using the formula (heart rate × [age / 10]) / systolic blood pressure, was shown to...
8.
Yokoyama K, Kaneko T, Ito A, Ieki Y, Kawamoto E, Suzuki K, et al.
Sci Rep . 2022 Sep; 12(1):16373. PMID: 36180581
Heatstroke is a life-threatening event that affects people worldwide. Currently, there are no established tools to predict the outcomes of heatstroke. Although the Sequential Organ Failure Assessment (SOFA) score is...
9.
Hane A, Ito A, Ishikura K, Imai H, Okugawa Y
Cureus . 2022 Jul; 14(6):e26351. PMID: 35903575
Cetuximab is a chimeric mouse-human monoclonal antibody biologic used for the treatment of epidermal growth factor receptor-positive colorectal cancer and head and neck cancer. The incidence of severe anaphylaxis after...
10.
Ishikura K, Katayama K, Hara A, Kotani H, Suzuki K, Kaneko T, et al.
CEN Case Rep . 2021 Nov; 11(2):269-272. PMID: 34817846
Bromvalerylurea is included in over-the-counter analgesics and is known to cause chronic bromism. Patients can also present acute intoxication because of suicide attempts. The treatment consists of drug cessation and...